Charles Warden

Charles Warden has been an active medical device venture investor since 1992. Charles works closely with entrepreneurial device companies from inception along the path to success. Prior to joining Versant in 2004, he was a general partner at Schroder Ventures Life Sciences (now SV Life Sciences) where he led SV’s medical device activity.

Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Before becoming a venture capitalist, Charles was a consultant with Monitor Company, a strategy consulting firm.

Charles has served on numerous medical device company boards, including the following currently: AcuFocus, Celula, Ceterix Orthopedics, Cotera, ForSight Vision4, Glumetrics, Halscion, Ocular Therapeutix, Twelve and WaveTec. Prior board memberships include Insulet (Nasdaq: PODD), Concentric Medical (acquired by Stryker) Confluent Surgical (acquired by Covidien), CardioFocus, Liposonix (acquired by Medicis), Sadra Medical (acquired by Boston Scientific), and Heritage Health Systems (acquired by Universal American Financial Corp). Since its inception, Charles has been actively involved with The Innovation Factory, a medical devices incubator. He is also involved in ForSight Labs, an ophthalmic incubator, and with The Foundry medical device incubator.

Charles holds a Bachelor’s degree from Beloit College and an MBA from Harvard Business School.